Corcept Therapeutics's market cap is currently $7.79B. The company's EPS TTM is $0.29; its P/E ratio is 65.82; Corcept Therapeutics is scheduled to report earnings on July 31, 2025, and the estimated EPS forecast is $0.14. See an overview of income statement, balance sheet, and cash flow financials.
